Sera Prognostics Q2 2024 net loss narrows to $8.3M; revenue drops to $24k

SERA PROGNOSTICS, INC.

2024-Q2 EPS reported -$0.50 revenue$24,000

Q2 2024 revenue was $24,000, down from $123,000 in Q2 2023.
Net loss improved 21% to $8.3M from $10.5M in Q2 2023.
Operating expenses decreased 20% to $9.3M; SG&A down 38% to $4.9M, R&D up 19% to $4.4M.
Published positive AVERT PRETERM TRIAL results; PRIME study database lock expected mid-September; NY State conditional approval for whole-blood collection.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.